Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease

The technology described in this briefing is Lenus COPD Support Service. It is a remote management service for people with high-risk chronic obstructive pulmonary disease (COPD).

The innovative aspects are the combination of data from patient-reported outcomes, medical and wearable devices, and clinical records.

The intended place in therapy would be in addition to standard care as part of the individualised care plan for people with high-risk COPD.

The main points from the evidence summarised in this briefing are from 3 publications that reported findings from 2 observational studies, including a total of 278 adults. These suggested that people using Lenus COPD Support Service had improved patient-reported outcomes and reduced respiratory-related hospital admissions and occupied bed days.

Key uncertainties around the evidence or technology are that the published evidence is limited to 1 non-peer-reviewed pre-print and abstracts that had limited details of methods and outcome data. Also, comparative analysis was limited to historical controls.

Experts advised that Lenus COPD Support Service could lead to earlier intervention for exacerbations and fewer hospital admissions. But more evidence is needed on the clinical and cost effectiveness of Lenus COPD Support Service. Experts also noted barriers to uptake of digital technologies and potential drawbacks for users and the NHS.

The cost of Lenus COPD Support Service is £10,000 (excluding VAT) for initial setup plus £30,000 yearly licence fee and £10 user fee per patient per month. There is a 20% discount on user fees for over 1,000 patients. Lenus COPD Support Service is an add-on to standard care.